The Journal of Allergy and Clinical Immunology
Volume 116, Issue 3 , Pages 517-524 , September 2005

Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma

  • Ming-Chun Wen, MD

      Affiliations

    • From the Weifang Asthma Hospital
    • Corresponding Author InformationMing-Chun Wen, MD, Weifang Asthma Hospital, Weifang, N0. 68, Xinhua Road, Weifang, Shandong 261041, China.
    • ,
  • Chun-Hua Wei, MD

      Affiliations

    • From the Weifang Asthma Hospital
    • ,
  • Zhao-Qiu Hu, MD, MS

      Affiliations

    • From the Weifang Asthma Hospital
    • ,
  • Kamal Srivastava, MPhil

      Affiliations

    • Department of Pediatrics
    • ,
  • Jimmy Ko, MD

      Affiliations

    • Department of Pediatrics
    • ,
  • Su-Ting Xi, MD, MS

      Affiliations

    • From the Weifang Asthma Hospital
    • ,
  • Dong-Zhen Mu, MD, MS

      Affiliations

    • Department of Immunology, Weifang School of Medicine
    • ,
  • Ji-Bin Du, MD

      Affiliations

    • From the Weifang Asthma Hospital
    • ,
  • Guo-Hua Li, MD

      Affiliations

    • From the Weifang Asthma Hospital
    • ,
  • Sylvan Wallenstein, PhD

      Affiliations

    • Department of Community Medicine, Mount Sinai School of Medicine, New York
    • ,
  • Hugh Sampson, MD

      Affiliations

    • Department of Pediatrics
    • ,
  • Meyer Kattan, MD

      Affiliations

    • Department of Pediatrics
    • ,
  • Xiu-Min Li, MD

      Affiliations

    • Department of Pediatrics
    • Corresponding Author InformationReprint requests: Xiu-Min Li, MD, Pediatric Allergy and Immunology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029-6574.

Received 20 January 2005 ,Revised 9 May 2005 ,Accepted 16 May 2005.

References 

  1. Leonard P, Sur S. Asthma: future directions. Med Clin North Am. 2002;86:1131–1156
  2. National Heart LaBI . Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol. 1991;88:425–534
  3. Gea-Banacloche JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C. Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med. 2004;32(suppl 11):S578–S590
  4. Eid N, Morton R, Olds B, Clark P, Sheikh S, Looney S. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics. 2002;109:217–221
  5. Visser MJ, van der Veer E, Postma DS, Arends LR, de Vries TW, Brand PL, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J. 2004;24(3):420–425
  6. Li XM, Huang CK, Zhang TF, Teper AA, Srivastava K, Schofield BH, et al. The chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma. J Allergy Clin Immunol. 2000;106:660–668
  7. Srivastava K, Teper AA, Zhang TF, Li S, Walsh MJ, Huang CK, et al. Immunomodulatory effect of the anti-asthma Chinese herbal formula, MSSM-002 on Th2 cells. J Allergy Clin Immunol. 2004;113:268–276
  8. Bensky D, Barolet R. Introduction. In:  Bensky D,  Barolet R editor. Chinese herbal medicine: formulas & strategies. Seattle (WA): Eastland Press; 1993;p. 466–467
  9. Li XM, Zhang TF, Sampson H, Zou ZM, Beyer K, Wen MC, et al. The potential use of Chinese herbal medicines in treating allergic asthma. Ann Allergy Asthma Immunol. 2004;93(suppl 1):S35–S44
  10. Busse PJ, Wen MC, Huang CK, Srivastava K, Zhang TF, Schofield B, et al. Therapeutic effects of the Chinese herbal formula, MSSM-03d, on persistent airway hyperreactivity and airway remodeling. [abstract] J Allergy Clin Immunol. 2004;113:S220–S221
  11. Srivastava K, Zou ZM, Sampson HA, Dansky H, Li XM. Direct modulation of airway reactivity by the Chinese anti-asthma herbal formula ASHMI [abstract]. J Allergy Clin Immunol 2005;115:S7.
  12. Ko J, Busse PJ, Shek L, Noone SA, Sampson HA, Li XM. Effect of Chinese herbal formulas on T cell responses in patients with peanut allergy or asthma [abstract]. J Allergy Clin Immunol 2005;115:S34.
  13. Global Initiative for Asthma. Global strategy for asthma management and prevention. National Institutes of Health. Bethesda (Md): National Heart, Lung, and Blood Institute; 2002.
  14. Franklin HR, Simonetti GP, Dubbelman AC, Bokkel Huinink WW, Taal BG, Wigbout G, et al. Toxicity grading systems: a comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Ann Oncol. 1994;5:113–117
  15. The Chinese respiratory Medical Science Institute. Asthma Educational Management Project Scheme. The Chinese Respiratory Medical Science Institute, The Chinese Pediatrics of Medical Science Institute, Asthma Study Group, 8-9. 2003.
  16. Zhang S. Eosinophil counting: clinical test. Chengdu (China): Sichuan Ke ji publishers; 1994;p. 13-8
  17. Backer V, Ulrik CS, Wendelboe D, Bach-Mortensen N, Hansen KK, Laursen EM, et al. Distribution of serum IgE in children and adolescents aged 7 to 16 years in Copenhagen, in relation to factors of importance. Allergy. 1992;47:484–489
  18. Barbee RA, Halonen M, Lebowitz M, Burrows B. Distribution of IgE in a community population sample: correlations with age, sex, and allergen skin test reactivity. J Allergy Clin Immunol. 1981;68:106–111
  19. Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. Clin Ther. 1999;21:353–367
  20. Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol. 1986;77:9–13
  21. Fei GH, Liu RY, Zhang ZH, Zhou JN. Alterations in circadian rhythms of melatonin and cortisol in patients with bronchial asthma. Acta Pharmacol Sin. 2004;25:651–656
  22. Kauffmann F, Guiochon-Mantel A, Neukirch F. Is low endogenous cortisol a risk factor for asthma?. Am J Respir Crit Care Med. 1999;160:1428
  23. Landstra AM, Postma DS, Boezen HM, van Aalderen WM. Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med. 2002;165:708–712
  24. Fong HHS, Farnsworth NR, Mahady GB. Radix Glycyrrhizae. In: WHO monographs on selected medicinal plants. Vol 1. Geneva: World Health Organization; 1999. p. 183-94.
  25. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171–1183
  26. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 2000;106(suppl 5):S201–S205
  27. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033–1039
  28. Yang M, Wu T, Cheng L, Wang F, Wei Q, Tanguay RM. Plasma antibodies against heat shock protein 70 correlate with the incidence and severity of asthma in a Chinese population. Respir Res. 2005;6:18
  29. Wang Q, Lin J, Sun H, Li J, Zhao W. The study of T helper cell subsets and relationship to relative cytokines and ventilatory function in asthmatic patients. Chin J Tuberc Respir Dis. 2000;23:147–151
  30. Tang A, Li J, Meng X, An F, Zhao K. Relationship between IL-4, Sicam-1, IFN-gama and IgE in allergic bronchial asthma. Zhong Guo Shiyong Neika Za Zhi (Chinese). 1999;39:665–666
  31. Jin SL. Study of effects and mechanisms of anti-anaphylaxis of LLA SFA GUF. J Harbin Med Sch. 1995;16:81–84
  32. Zieg G, Lack G, Harbeck RJ, Gelfand EW, Leung DY. In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol. 1994;94:222–230
  33. Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol. 1978;62:162–166
  34. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol. 2003;111(suppl 3):S799–S804
  35. Salek-Ardakani S, Song J, Halteman BS, Jember AG, Akiba H, Yagita H, et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med. 2003;198:315–324
  36. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111:450–463
  37. Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay AB, Corrigan CJ. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax. 1994;49:1231–1233
  38. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833–1838
  39. The State Pharmacopoeia Commission of the People's Republic of China. Pharmacopoeia of the People's Republic of China. Beijing, China: Chemical Industry Press; 2000;
  40. Hope BE, Massey DG, Fournier-Massey G. Hawaiian materia medica for asthma. Hawaii Med J. 1993;52:160–166
  41. Hu KM, He YM. Correlation between complex prescription with lucid ganoderma in treating rhinoallergosis and constitute. Shanghai J Tradit Chin Med. 2000;8:39–41
  42. Liu J, Zhu M, Shi R, Yang M. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials. Am J Chin Med. 2003;31:337–354
  43. Massey DG, Chien YK, Fournier-Massey G. Mamane: scientific therapy for asthma?. Hawaii Med J. 1994;53:350–35163
  44. Peirce A. The American Pharmaceutical Association practical guide to natural medicines. 1st ed.. New York: William Morrow; 1999;
  45. Yu QH, Wang PX, Liu L, Liu FJ, Liu LH, Liu MP, et al. Immunoherbology of traditional Chinese medicine: immunology, pharmacology and clinic: Ling Zhi. In:  Luo HS,  Luo DH editor. Beijing: Beijing Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College Union Publisher; 1999;p. 54–60
  46. Yu QH, Wang PX, Liu L, Liu FJ, Liu LH, Liu MP, et al. Immunoherbology of traditional Chinese medicine: immunology, pharmacology and clinic: Ku-Shen. In:  Luo HS,  Luo DH editor. Beijing: Beijing Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College Union Publisher; 1999;p. 208–213

 Supported by National Institutes of Health grant # AT001495-01A1.Disclosure of potential conflict of interest: M.-C. Wen has filed a US patent application (reference #60554775). H. Sampson has received grants/research support from the National Institutes of Health and has filed a US patent application (reference #60554775). M. Kaltan is on the speakers' bureau for AstraZeneca. X.-M. Li has received grants/research support from the National Institutes of Health and has filed a US patent application (reference #60554775).

PII: S0091-6749(05)01358-8

doi: 10.1016/j.jaci.2005.05.029

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 3 , Pages 517-524 , September 2005

Article Tools

* Image Usage & Resolution